{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:43:12Z","timestamp":1792719792070,"version":"4.5.0"},"publisher-location":"Cham","reference-count":156,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030203146","type":"print"},{"value":"9783030203153","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-20315-3_2","type":"book-chapter","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T05:05:44Z","timestamp":1563339944000},"page":"11-36","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients"],"prefix":"10.1007","author":[{"given":"Anna","family":"Falanga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schieppati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/jth.12075","volume":"11","author":"A Falanga","year":"2013","unstructured":"Falanga A, Marchetti M, Vignoli A (2013) Coagulation and cancer: biological and clinical aspects. J Thromb Haemost 11:223\u2013233","journal-title":"J Thromb Haemost"},{"issue":"90231","key":"2_CR2","doi-asserted-by":"publisher","first-page":"17I--21","DOI":"10.1161\/01.CIR.0000078466.72504.AC","volume":"107","author":"A. Y.Y. Lee","year":"2003","unstructured":"Lee AYY, Levine MN (2003) Venous thromboembolism and cancer: risks and outcomes. Circulation 107(Suppl 23)","journal-title":"Circulation"},{"issue":"10","key":"2_CR3","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","volume":"122","author":"JF Timp","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC (2013) Epidemiology of venous thrombosis. Blood 122(10):1712\u20131723","journal-title":"Blood"},{"issue":"3","key":"2_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","volume":"4","author":"JW Blom","year":"2006","unstructured":"Blom JW, Vanderschoot JPM, Oostindi\u00ebr MJ, Osanto S, van der Meer FJM, Rosendaal FR (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4(3):529\u2013535","journal-title":"J Thromb Haemost"},{"issue":"293","key":"2_CR5","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jama.293.6.715","volume":"9","author":"J Blom","year":"2005","unstructured":"Blom J, Doggen C, Osanto S, Rosendaal F (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 9(293):715\u2013722","journal-title":"JAMA"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.5482\/ha-1170","volume":"32","author":"A Falanga","year":"2012","unstructured":"Falanga A, Russo L (2012) Epidemiology, risk and outcomes of venous thromboembolism in cancer. Hamostaseologie 32:115\u2013125","journal-title":"Hamostaseologie"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MOH.0000000000000072","volume":"21","author":"A Falanga","year":"2014","unstructured":"Falanga A, Russo L, Milesi V (2014) The coagulopathy of cancer. Curr Opin Hematol 21:423\u2013429","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 2","key":"2_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0049-3848(14)50001-1","volume":"133","author":"N Magnus","year":"2014","unstructured":"Magnus N, D\u2019Asti E, Meehan B, Garnier D, Rak J (2014) Oncogenes and the coagulation system\u2014forces that modulate dormant and aggressive states in cancer. Thromb Res 133(Suppl 2):S1\u2013S9","journal-title":"Thromb Res"},{"issue":"Suppl 2","key":"2_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0049-3848(14)50006-0","volume":"133","author":"AA Khorana","year":"2014","unstructured":"Khorana AA, McCrae KR (2014) Risk stratification strategies for cancer-associated thrombosis: an update. Thromb Res 133(Suppl 2):35\u201338","journal-title":"Thromb Res"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S0049-3848(15)50432-5","volume":"135","author":"A Falanga","year":"2015","unstructured":"Falanga A, Marchetti M, Russo L (2015) The mechanisms of cancer-associated thrombosis. Thromb Res 135:S8\u2013S11","journal-title":"Thromb Res"},{"issue":"12","key":"2_CR11","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1002\/cncr.21496","volume":"104","author":"AA Khorana","year":"2005","unstructured":"Khorana AA, Francis CW, Culakova E, Lyman GH (2005) Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 104(12):2822\u20132829","journal-title":"Cancer"},{"issue":"1","key":"2_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1538-7836.2009.03680.x","volume":"8","author":"R Simanek","year":"2010","unstructured":"Simanek R, Vormittag R, Ay C, Alguel G, Dunkler D, Schwarzinger I et al (2010) High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 8(1):114\u2013120","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2_CR13","doi-asserted-by":"publisher","first-page":"e22946","DOI":"10.4161\/onci.22946","volume":"2","author":"M\u00e9lanie Demers","year":"2013","unstructured":"Demers M, Wagner DD (2003) Neutrophil extracellular traps: a new link to cancer-associated thrombosis and potential implications for tumor progression. Oncoimmunology 2(2)","journal-title":"OncoImmunology"},{"issue":"10","key":"2_CR14","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","volume":"111","author":"AA Khorana","year":"2008","unstructured":"Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10):4902\u20134907","journal-title":"Blood"},{"issue":"24","key":"2_CR15","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","volume":"116","author":"C Ay","year":"2010","unstructured":"Ay C, Dunkler D, Marosi C, Chiriac A-L, Vormittag R, Simanek R et al (2010) Prediction of venous thromboembolism in cancer patients. Blood 116(24):5377\u20135382","journal-title":"Blood"},{"issue":"25","key":"2_CR16","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","volume":"29","author":"RA Moore","year":"2011","unstructured":"Moore RA, Adel N, Riedel E, Bhutani M, Feldman DR, Tabbara NE et al (2011) High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: A large retrospective analysis. J Clin Oncol 29(25):3466\u20133473","journal-title":"J Clin Oncol"},{"issue":"1","key":"2_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","volume":"33","author":"DG Menter","year":"2014","unstructured":"Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV (2014) Platelets and cancer: a casual or causal relationship: Revisited. Cancer Metastasis Rev 33(1):231\u2013269","journal-title":"Cancer Metastasis Rev"},{"key":"2_CR18","doi-asserted-by":"crossref","unstructured":"Gran OV, Braekkan SK, Hansen JB (2018) Prothrombotic genotypes and risk of venous thromboembolism in cancer. Thromb Res","DOI":"10.1016\/j.thromres.2017.12.025"},{"issue":"9159","key":"2_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","volume":"353","author":"F Rosendaal","year":"1999","unstructured":"Rosendaal F (1999) Venous thrombosis: a multicausal disease. Lancet 353(9159):1167\u20131173","journal-title":"Lancet"},{"issue":"Suppl 2","key":"2_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0049-3848(07)70130-5","volume":"120","author":"H Decousus","year":"2007","unstructured":"Decousus H, Moulin N, Quenet S, Bost V, Rivron-Guillot K, Laporte S et al (2007) Thrombophilia and risk of venous thrombosis in patients with cancer. Thromb Res 120(Suppl 2):51\u201361","journal-title":"Thromb Res"},{"issue":"1","key":"2_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/jth.12778","volume":"13","author":"I Pabinger","year":"2015","unstructured":"Pabinger I, Ay C, Dunkler D, Thaler J, Reitter EM, Marosi C et al (2015) Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients\u2014results from the Vienna Cancer And Thrombosis Study (CATS). J Thromb Haemost 13(1):17\u201322","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2_CR22","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3324\/haematol.2016.147405","volume":"101","author":"OV Gran","year":"2016","unstructured":"Gran OV, Smith EN, Br\u00e6kkan SK, Jensvoll H, Solomon T, Hindberg K et al (2016) Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism. Haematologica 101(9):1046\u20131053","journal-title":"Haematologica"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1538-7836.2007.02823.x","volume":"6","author":"F Dentali","year":"2007","unstructured":"Dentali F, Gianni M, Agnelli G, Ageno W (2007) Association between inherited thrombophilic abnormalities and central venous catheter thrombosis in patients with cancer: results of the CAVECCAS study. J Thromb Haemost 6:70\u201375","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(69)91955-2","volume":"15","author":"H Jick","year":"1969","unstructured":"Jick H, Slone D, Westerholm B, Inman W, Vessey M, Shapiro S et al (1969) Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 15(1):539\u2013542","journal-title":"Lancet"},{"issue":"5","key":"2_CR25","doi-asserted-by":"publisher","first-page":"E229","DOI":"10.1503\/cmaj.121636","volume":"185","author":"BF Sode","year":"2013","unstructured":"Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG (2013) Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ 185(5):E229\u2013E237","journal-title":"CMAJ"},{"issue":"1","key":"2_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","volume":"22","author":"T Wun","year":"2009","unstructured":"Wun T, White RH (2009) Epidemiology of cancer-related venous thromboembolism. Best Pr Res Clin Haematol 22(1):9\u201323","journal-title":"Best Pr Res Clin Haematol"},{"issue":"10","key":"2_CR27","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/cncr.23062","volume":"110","author":"AA Khorana","year":"2007","unstructured":"Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110(10):2339\u20132346","journal-title":"Cancer"},{"issue":"3","key":"2_CR28","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.thromres.2011.10.025","volume":"129","author":"A Falanga","year":"2012","unstructured":"Falanga A, Marchetti M (2012) Anticancer treatment and thrombosis. Thromb Res 129(3):353\u2013359","journal-title":"Thromb Res"},{"issue":"2","key":"2_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/s-2008-1079261","volume":"34","author":"D Lechner","year":"2008","unstructured":"Lechner D, Weltermann A (2008) Chemotherapy-induced thrombosis: a role for microparticles and tissue factor? Semin Thromb Hemost 34(2):199\u2013203","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"2_CR30","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/bjs.1800820831","volume":"82","author":"A Kakkar","year":"1995","unstructured":"Kakkar A, Lemoine N, Scully M, Tebbutt S, Williamson R (1995) Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 82(8):1101\u20131104","journal-title":"Br J Surg"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1877::AID-CNCR18>3.0.CO;2-X","volume":"77","author":"K Hamada","year":"1996","unstructured":"Hamada K, Kuratsu J, Saitoh Y, Takeshima H, Nishi T, Ushio Y (1996) Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 77:1877\u20131883","journal-title":"Cancer"},{"issue":"12","key":"2_CR32","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1054\/bjoc.2000.1150","volume":"82","author":"S Takano","year":"2000","unstructured":"Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T (2000) Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer 82(12):1967\u20131973","journal-title":"Br J Cancer"},{"issue":"4","key":"2_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0009-9120(02)00312-0","volume":"35","author":"M Guan","year":"2002","unstructured":"Guan M, Jin J, Su B, Liu W, Lu Y (2002) Tissue factor expression and angiogenesis in human glioma. Clin Biochem 35(4):321\u2013325","journal-title":"Clin Biochem"},{"key":"2_CR34","first-page":"1133","volume":"10","author":"K Ishimaru","year":"2003","unstructured":"Ishimaru K, Hirano H, Yamahata H, Takeshima H, Niiro M, Kuratsu J (2003) The expression of tissue factor correlates with proliferative ability in meningioma. Oncol Rep 10:1133\u20131137","journal-title":"Oncol Rep"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1538-7836.2006.01985.x","volume":"4","author":"RS Fernandes","year":"2006","unstructured":"Fernandes RS, Kirszbeg C, Rumjanek M, Monteiro RQ (2006) On the molecular mechanisms for the highly procoagulant pattern of C6 glioma cells. J Thromb Haemost 4:1546\u20131552","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2_CR36","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1182\/blood-2004-05-2042","volume":"105","author":"JL Yu","year":"2005","unstructured":"Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI et al (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105(4):1734\u20131742","journal-title":"Blood"},{"key":"2_CR37","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","volume":"6","author":"M Davila","year":"2008","unstructured":"Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J et al (2008) Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6:1517\u20131524","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2_CR38","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1073\/pnas.1314118111","volume":"111","author":"N Magnus","year":"2014","unstructured":"Magnus N, Garnier D, Meehan B, Mcgraw S, Hoon T, Caron M (2014) Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations. PNAS 111(9):3544\u20133549","journal-title":"PNAS"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.critrevonc.2017.08.003","volume":"118","author":"A Falanga","year":"2017","unstructured":"Falanga A, Russo L, Milesi V, Vignoli A (2017) Mechanisms and risk factors of thrombosis in cancer. Crit Rev Oncol Hematol 118:79\u201383","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2_CR40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V92.1.143.413k18_143_151","volume":"92","author":"A Falanga","year":"1998","unstructured":"Falanga A, Consonni R, Marchetti M, Locatelli G, Garattini E, Gambacorti Passerini C et al (1998) Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 92(1):143\u2013151","journal-title":"Blood"},{"issue":"3","key":"2_CR41","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1182\/blood.V86.3.1072.1072","volume":"86","author":"A Falanga","year":"1995","unstructured":"Falanga A, Iacoviello L, Evangelista V, Belotti D, Consonni R, D\u2019Orazio A et al (1995) Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 86(3):1072\u20131081","journal-title":"Blood"},{"key":"2_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/ajh.10073","volume":"70","author":"A Falanga","year":"2002","unstructured":"Falanga A, Toma S, Marchetti M, Palumbo R, Raffo P, Consonni R et al (2002) Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer. Am J Hematol 70:9\u201315","journal-title":"Am J Hematol"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/S0049-3848(14)50015-1","volume":"133","author":"Y Nadir","year":"2014","unstructured":"Nadir Y, Brenner B (2014) Heparanase multiple effects in cancer. Thromb Res. Elsevier Masson SAS 133:S90\u2013S94","journal-title":"Thromb Res. Elsevier Masson SAS"},{"key":"2_CR44","first-page":"5968","volume":"9","author":"X Xu","year":"2003","unstructured":"Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB et al (2003) Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Clin Cancer Res 9:5968\u20135979","journal-title":"Clin Cancer Res"},{"issue":"May","key":"2_CR45","first-page":"1299","volume":"7","author":"ON El-assal","year":"2001","unstructured":"El-assal ON, Yamanoi A, Ono T, Kohno H, Nagasue N (2001) The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma. Clin Cancer Res 7(May):1299\u20131305","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2_CR46","first-page":"393","volume":"130","author":"J Folkman","year":"1988","unstructured":"Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I (1988) A heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am J Pathol 130(2):393\u2013400","journal-title":"Am J Pathol"},{"issue":"April","key":"2_CR47","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1073\/pnas.84.8.2292","volume":"84","author":"I Vlodavsky","year":"1987","unstructured":"Vlodavsky I, Folkmantt J, Sullivant R, Fridman R, Ishai-michaeli R, Sasset J et al (1987) Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Nati Acad Sci USA 84(April):2292\u20132296","journal-title":"Proc Nati Acad Sci USA"},{"issue":"4","key":"2_CR48","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0002-9440(10)64632-9","volume":"157","author":"Yael Friedmann","year":"2000","unstructured":"Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, et al (2000) Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. evidence for its role in colonic tumorigenesis. Am J Pathol 157(4):1167\u20131175","journal-title":"The American Journal of Pathology"},{"issue":"9","key":"2_CR49","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1096\/fj.00-0895fje","volume":"15","author":"M Elkin","year":"2001","unstructured":"Elkin M, Ilan N, Ishai-Michaeli R, Friedmann Y, Papo O, Pecker I et al (2001) Heparanase as mediator of angiogenesis: mode of action. FASEB J 15(9):1661\u20131663","journal-title":"FASEB J"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/S0049-3848(16)30097-4","volume":"140","author":"Y Nadir","year":"2016","unstructured":"Nadir Y, Brenner B (2016) Heparanase procoagulant activity in cancer progression. Thromb Res 140:S44\u2013S48","journal-title":"Thromb Res"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1538-7836.2005.01347.x","volume":"3","author":"YS Ahn","year":"2005","unstructured":"Ahn YS (2005) Cell-derived microparticles: \u201cMiniature envoys with many faces\u201d. J Thromb Haemost 3:884\u2013887","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2302\/kjm.53.210","volume":"53","author":"LL Horstman","year":"2004","unstructured":"Horstman LL, Jy W, Jimenez JJ, Bidot C, Ahn YS (2004) New horizons in the analysis of circulating cell-derived microparticles. Keio J Med 53(4):210\u2013230","journal-title":"Keio J Med"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/0021-9150(95)05551-7","volume":"116","author":"S Nomura","year":"1995","unstructured":"Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T et al (1995) Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 116:235\u2013240","journal-title":"Atherosclerosis"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.CIR.101.8.841","volume":"101","author":"Z Mallat","year":"2000","unstructured":"Mallat Z, Benamer H (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood. Circulation 101:841\u2013843","journal-title":"Circulation"},{"key":"2_CR55","doi-asserted-by":"crossref","unstructured":"Nieuwland R, Berckmans J, Mcgregor S, Bo AN, Romijn FPHTM, Westendorp RGJ, et al (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95(3):930\u2013936","DOI":"10.1182\/blood.V95.3.930.003k46_930_935"},{"issue":"9","key":"2_CR56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jacc.2004.12.075","volume":"45","author":"Julio A. Chirinos","year":"2005","unstructured":"Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, et al (2005) Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. Elsevier Masson SAS 45(9):1467\u20131471","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"2_CR57","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1055\/s-2006-951297","volume":"32","author":"A Piccioli","year":"2006","unstructured":"Piccioli A, Falanga A, Baccaglini U, Marchetti M, Prandoni P (2006) Cancer and venous thromboembolism. Semin Thromb Hemost 32(7):694\u2013699","journal-title":"Semin Thromb Hemost"},{"issue":"29","key":"2_CR58","doi-asserted-by":"publisher","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","volume":"27","author":"A Falanga","year":"2009","unstructured":"Falanga A, Marchetti M (2009) Venous thromboembolism in the hematologic malignancies. J Clin Oncol 27(29):4848\u20134857","journal-title":"J Clin Oncol"},{"issue":"2","key":"2_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0959-8049(02)00596-8","volume":"39","author":"H Kim","year":"2003","unstructured":"Kim H, Song K, Park Y, Kang Y, Lee Y, Lee K et al (2003) Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39(2):184\u2013191","journal-title":"Eur J Cancer"},{"issue":"1","key":"2_CR60","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1538-7836.2006.02301.x","volume":"5","author":"I Conde Del","year":"2007","unstructured":"Del Conde I, Bharwani LD, Dietzen DJ, Pendurthi U, Thiagarajan P, L\u00f3Pez JA (2007) Microvesicle-associated tissue factor and Trousseau\u2019s syndrome. J Thromb Haemost 5(1):70\u201374","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2_CR61","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.thromres.2007.12.023","volume":"122","author":"RE Tilley","year":"2008","unstructured":"Tilley RE, Holscher T, Belani R, Nieva J, Mackman J (2008) Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 122(5):604\u2013609","journal-title":"Thromb Res"},{"issue":"2","key":"2_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-2008-1079262","volume":"34","author":"A Falanga","year":"2008","unstructured":"Falanga A, Barbui T, Rickles FR (2008) Hypercoagulability and tissue factor gene upregulation in hematologic malignancies. Semin Thromb Hemost 34(2):204\u2013210","journal-title":"Semin Thromb Hemost"},{"issue":"4497","key":"2_CR63","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.7195067","volume":"212","author":"H. Dvorak","year":"1981","unstructured":"Dvorak HF, Quay SC, Orenstein NS, Dvorak AM, Hahn P, Bitzer AM, et al (1981) Tumor shedding and coagulation. Science 212(4497):923\u2013924","journal-title":"Science"},{"issue":"1","key":"2_CR64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood.V64.1.177.177","volume":"64","author":"E Bastida","year":"1984","unstructured":"Bastida E, Ordinas A, Escolar G, Jamieson GA (1984) Tissue factor in microvescicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64(1):177\u2013184","journal-title":"Blood"},{"issue":"11","key":"2_CR65","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1111\/j.1538-7836.2004.00972.x","volume":"2","author":"JL Yu","year":"2004","unstructured":"Yu JL, Rak JW (2004) Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2(11):2065\u20132067","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2_CR66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","volume":"5","author":"M. E. T. TESSELAAR","year":"2007","unstructured":"Tesselaar MET, Romijn FPHTM, Van Der Linden IK, Prins FA, Bertina RM, Osanto S (2006) Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5:520\u2013527","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6","key":"2_CR67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.thromres.2009.09.019","volume":"125","author":"DA Manly","year":"2010","unstructured":"Manly DA, Wang J, Glover SL, Kasthuri R, Liebman HA, Key S et al (2010) Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb Res 125(6):511\u2013512","journal-title":"Thromb Res"},{"issue":"8","key":"2_CR68","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1055\/s-0030-1267045","volume":"36","author":"HC Kwaan","year":"2010","unstructured":"Kwaan HC, Magalha E (2010) Role of microparticles in the hemostatic dysfunction in acute promyelocytic leukemia. Semin Thromb Hemost 36(8):917\u2013924","journal-title":"Semin Thromb Hemost"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1538-7836.2010.04133.x","volume":"9","author":"MC Aalderen van","year":"2011","unstructured":"van Aalderen MC, Trappenburg MC, van Schilfgaarde M, Molenaar PJ (2011) Procoagulant myeloblast-derived microparticles in AML patients: changes in numbers and thrombin generation potential during chemotherapy. J Thromb Haemost 9:223\u2013234","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2_CR70","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1160\/TH10-03-0187","volume":"105","author":"JJ Auwerda","year":"2011","unstructured":"Auwerda JJ, Yuana Y, Osanto S, de Maat MP, Sonneveld P, Bertina RM et al (2011) Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 105(1):14\u201320","journal-title":"Thromb Haemost"},{"issue":"7","key":"2_CR71","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3324\/haematol.13774","volume":"94","author":"MC Trappenburg","year":"2009","unstructured":"Trappenburg MC, Van Schilfgaarde M, Marchetti M, Spronk HM, Cate H, Leyte A et al (2009) Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 94(7):911\u2013998","journal-title":"Haematologica"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1161\/CIRCRESAHA.110.233049","volume":"109","author":"MC Martinez","year":"2011","unstructured":"Martinez MC, Andriantsitohaina R (2011) Microparticles in angiogenesis: therapeutic potential. Circ Res 109:110\u2013119","journal-title":"Circ Res"},{"key":"2_CR73","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1365-2141.2003.04773.x","volume":"124","author":"HK Kim","year":"2004","unstructured":"Kim HK, Song KS, Chung J, Lee KR, Lee S (2004) Platelet microparticles induce angiogenesis in vitro. Br J Haematol 124:376\u2013384","journal-title":"Br J Haematol"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ijc.20657","volume":"113","author":"A Janowska-wieczorek","year":"2004","unstructured":"Janowska-wieczorek A, Wysoczynski M, Kijowski J, Marquez-curtis L, Machalinski B, Ratajczak J et al (2004) Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113:752\u2013760","journal-title":"Int J Cancer"},{"issue":"11","key":"2_CR75","first-page":"673","volume":"1","author":"A Falanga","year":"2003","unstructured":"Falanga A, Marchetti M, Vignoli A, Balducci D (2003) Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. Clin Adv Hematol Oncol 1(11):673\u2013678","journal-title":"Clin Adv Hematol Oncol"},{"issue":"125","key":"2_CR76","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S0049-3848(10)70010-4","volume":"2018","author":"W Ruf","year":"2010","unstructured":"Ruf W, Yokota N, Schaffner F (2010) Tissue factor in cancer progression and angiogenesis. Thromb Res 2018(125):S36\u2013S38","journal-title":"Thromb Res"},{"issue":"24","key":"2_CR77","doi-asserted-by":"publisher","first-page":"10068","DOI":"10.1158\/0008-5472.CAN-08-2067","volume":"68","author":"CC Milsom","year":"2008","unstructured":"Milsom CC, Yu JL, Mackman N, Micallef J, Anderson GM, Guha A et al (2008) Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res 68(24):10068\u201310077","journal-title":"Cancer Res"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/S0049-3848(10)70022-0","volume":"125","author":"JI Zwicker","year":"2010","unstructured":"Zwicker JI (2010) Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb Res. Elsevier Ltd 125:S89\u2013S91","journal-title":"Thromb Res. Elsevier Ltd"},{"issue":"39","key":"2_CR79","doi-asserted-by":"publisher","first-page":"22988","DOI":"10.1074\/jbc.270.39.22988","volume":"270","author":"D Erdmann","year":"1995","unstructured":"Erdmann D, Heim J (1995) Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 270(39):22988\u201322996","journal-title":"J Biol Chem"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1084\/jem.159.4.1042","volume":"159","author":"BYBP Tsao","year":"1984","unstructured":"Tsao BYBP, Fair DS, Curtiss LK, Edgington TS (1984) Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII\/VIIa protease activity. J Exp Med 159:1042\u20131057","journal-title":"J Exp Med"},{"issue":"6","key":"2_CR81","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1172\/JCI111922","volume":"75","author":"H A Chapman","year":"1985","unstructured":"Chapman HA Jr, Allen CL, Stone OL, Fair DS. Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest 75:2030\u20132037","journal-title":"Journal of Clinical Investigation"},{"issue":"45","key":"2_CR82","doi-asserted-by":"publisher","first-page":"35565","DOI":"10.1074\/jbc.M006101200","volume":"275","author":"V Neaud","year":"2000","unstructured":"Neaud V, Hisaka T, Monvoisin A, Bedin C, Balabaud C, Foster DC et al (2000) Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 275(45):35565\u201335569","journal-title":"J Biol Chem"},{"issue":"9","key":"2_CR83","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1172\/JCI7750","volume":"104","author":"EG Fischer","year":"1999","unstructured":"Fischer EG, Riewald M, Huang HY, Miyagi Y, Kubota Y, Mueller BM et al (1999) Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 104(9):1213\u20131221","journal-title":"J Clin Invest"},{"issue":"15","key":"2_CR84","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/jnci\/85.15.1225","volume":"85","author":"LR Zacharski","year":"1993","unstructured":"Zacharski LR, Memoli VA, Ornstein DL, Rousseau SM, Kisiel W, Kudryk BJ (1993) Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Cancer Inst 85(15):1225\u20131230","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2_CR85","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1055\/s-0037-1614896","volume":"82","author":"Leo Zacharski","year":"1999","unstructured":"Wojtukiewicz MZ, Zacharski LR, Ruci\u00f1ska M, Zimnoch L, Jaromin J, R\u00f3za\u00f1ska-Kudelska M, et al (1999) Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma. Thromb Haemost 82:1659\u20131662","journal-title":"Thrombosis and Haemostasis"},{"issue":"19","key":"2_CR86","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.1158\/0008-5472.CAN-06-1803","volume":"66","author":"S Koizume","year":"2006","unstructured":"Koizume S, Jin M-S, Miyagi E, Hirahara F, Nakamura Y, Piao J-H et al (2006) Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res 66(19):9453\u20139460","journal-title":"Cancer Res"},{"issue":"24","key":"2_CR87","first-page":"3559","volume":"123","author":"J Tang","year":"2010","unstructured":"Tang J, Fan Q, Wu W, Jia Z, Li H, Yang Y et al (2010) Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis. Chin Med J 123(24):3559\u20133565","journal-title":"Chin Med J"},{"issue":"12","key":"2_CR88","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/sj.bjc.6605406","volume":"101","author":"N Yokota","year":"2009","unstructured":"Yokota N, Koizume S, Miyagi E, Hirahara F, Nakamura Y, Kikuchi K et al (2009) Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells. Br J Cancer 101(12):2023\u20132029","journal-title":"Br J Cancer"},{"issue":"7","key":"2_CR89","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1056\/NEJM200008173430702","volume":"343","author":"PA Kyrle","year":"2000","unstructured":"Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B et al (2000) High plasma levels of factor VIII and the Risk of recurrent venous thromboembolism. N Engl J Med 343(7):457\u2013462","journal-title":"N Engl J Med"},{"issue":"4","key":"2_CR90","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1365-2141.2003.04795.x","volume":"124","author":"C Legnani","year":"2004","unstructured":"Legnani C, Cosmi B, Cini M, Frascaro M, Giuliana G, Palareti G (2004) High plasma levels of factor VIII and risk of recurrence of venous thromboembolism. Br J Haematol 124(4):504\u2013510","journal-title":"Br J Haematol"},{"issue":"2","key":"2_CR91","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3324\/haematol.10454","volume":"92","author":"JJA Auwerda","year":"2007","unstructured":"Auwerda JJA, Sonneveld P, De Maat MPM, Leebeek FWG (2007) Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma. Haematologica 92(2):279\u2013280","journal-title":"Haematologica"},{"issue":"8","key":"2_CR92","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.ejim.2007.06.036","volume":"19","author":"Engin Yigit","year":"2008","unstructured":"Yigit E, G\u00f6n\u00fcll\u00fc G, Y\u00fccel I, Turgut M, Erdem D, \u00c7akar B (2008) Relation between hemostatic parameters and prognostic\/predictive factors in breast cancer. Eur J Intern Med 19(8):602\u2013607","journal-title":"European Journal of Internal Medicine"},{"issue":"1","key":"2_CR93","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/172460080802300106","volume":"23","author":"S Battistelli","year":"2008","unstructured":"Battistelli S, Stefanoni M, Lorenzi B, Dell\u2019Avanzato R, Varrone F, Pascucci A et al (2008) Coagulation factor levels in non-metastatic colorectal cancer patients. Int J Biol Markers 23(1):36\u201341","journal-title":"Int J Biol Markers"},{"issue":"4","key":"2_CR94","first-page":"206","volume":"21","author":"M. Dogan","year":"2006","unstructured":"Dogan M, Demirkazik A, Konuk N, Yalcin, Buyukcelik A, Utkan G, et al (2006) The effect of venous thromboembolism on survival of cancer patients and its relationship with serum level of factor VIII and vascular endothelial growth factor: a prospective matched-paired study. Int J Biol Markers 21(4):206\u2013210","journal-title":"The International Journal of Biological Markers"},{"issue":"12","key":"2_CR95","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/ATVBAHA.109.190827","volume":"29","author":"R Vormittag","year":"2009","unstructured":"Vormittag R, Simanek R, Ay C, Dunkler D, Quehenberger P, Marosi C et al (2009) High factor VIII levels independently predict venous thromboembolism in cancer patients: The cancer and thrombosis study. Arterioscler Thromb Vasc Biol 29(12):2176\u20132181","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"2_CR96","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/1097-0142(19920615)69:12<2884::AID-CNCR2820691204>3.0.CO;2-S","volume":"69","author":"A Andr\u00e9n-Sandberg","year":"1992","unstructured":"Andr\u00e9n-Sandberg A, Lecander I, Martinsson G, Astedt B (1992) Peaks in plasma plasminogen activator inhibitor-1 concentration may explain thrombotic events in cases of pancreatic carcinoma. Cancer 69(12):2884\u20132887","journal-title":"Cancer"},{"issue":"4","key":"2_CR97","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1158\/1078-0432.CCR-03-0198","volume":"10","author":"FL Sciacca","year":"2004","unstructured":"Sciacca FL, Ciusani E, Silvani A, Corsini E, Frigerio S, Pogliani S et al (2004) Genetic and plasma markers of venous thromboembolism in patients with high grade glioma. Clin Cancer Res 10(4):1312\u20131317","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-018-0930-x","volume":"14","author":"N Chen","year":"2015","unstructured":"Chen N, Ren M, Li R, Deng X, Li Y, Yan K et al (2015) Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma. Mol Cancer 14(1):1\u20137","journal-title":"Mol Cancer"},{"issue":"7","key":"2_CR99","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.leukres.2010.11.008","volume":"35","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang Z, Jiang M, Dai L, Zhang W, Wu D et al (2011) The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemia. Leuk Res 35(7):879\u2013884","journal-title":"Leuk Res"},{"issue":"3","key":"2_CR100","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/j.seminoncol.2014.04.009","volume":"41","author":"Gregory C. Connolly","year":"2014","unstructured":"Connolly GC, Phipps RP, Francis CW (2014) Platelets and cancer-associated thrombosis. Semin Oncol. Elsevier 41(3):302\u2013310","journal-title":"Seminars in Oncology"},{"key":"2_CR101","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0049-3848(13)70024-0","volume":"131","author":"A Falanga","year":"2013","unstructured":"Falanga A, Russo L, Verzeroli C (2013) Mechanisms of thrombosis in cancer. Thromb Res. Elsevier Ltd 131:S59\u2013S62","journal-title":"Thromb Res. Elsevier Ltd"},{"issue":"November","key":"2_CR102","first-page":"1","volume":"4","author":"EC Lee","year":"2017","unstructured":"Lee EC, Cameron SJ (2017) Cancer and thrombotic risk: the platelet paradigm. Front Cardiovasc Med. 4(November):1\u20136","journal-title":"Front Cardiovasc Med."},{"issue":"3","key":"2_CR103","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.semcancer.2010.04.005","volume":"20","author":"H L\u00e4ubli","year":"2010","unstructured":"L\u00e4ubli H, Borsig L (2010) Selectins promote tumor metastasis. Semin Cancer Biol 20(3):169\u2013177","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"2_CR104","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00005-006-0010-6","volume":"54","author":"M Chen","year":"2006","unstructured":"Chen M, Geng JG (2006) P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasis. Arch Immunol Ther Exp (Warsz) 54(2):75\u201384","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"Suppl 2","key":"2_CR105","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0049-3848(14)50025-4","volume":"133","author":"D Stegner","year":"2014","unstructured":"Stegner D, D\u00fctting S, Nieswandt B (2014) Mechanistic explanation for platelet contribution to cancer metastasis. Thromb Res 133(Suppl 2):149\u2013157","journal-title":"Thromb Res"},{"issue":"1","key":"2_CR106","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1182\/blood-2004-06-2272","volume":"105","author":"JS Palumbo","year":"2005","unstructured":"Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW (2005) Platelets and fibrin (ogen) increase metastatic potential by impeding natural killer cell\u2014mediated elimination of tumor cells. Blood J 105(1):178\u2013185","journal-title":"Blood J"},{"key":"2_CR107","unstructured":"Raica M, Cimpean AM, Ribatti D (2008) The role of podoplanin in tumor progression and metastasis. Anticancer Res 28(5B):2997\u20133006"},{"issue":"13","key":"2_CR108","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1182\/blood-2016-06-720714","volume":"129","author":"J Riedl","year":"2017","unstructured":"Riedl J, Preusser M, Nazari PMS, Posch F, Panzer S, Marosi C et al (2017) Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism. Blood 129(13):1831\u20131839","journal-title":"Blood"},{"issue":"40","key":"2_CR109","doi-asserted-by":"crossref","first-page":"42733","DOI":"10.18632\/oncotarget.5811","volume":"6","author":"Y-W Chang","year":"2015","unstructured":"Chang Y-W, Hsieh P, Chang Y, Lu M, Huang T-F, Chong K-Y et al (2015) Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis. Oncotarget 6(40):42733\u201342748","journal-title":"Oncotarget"},{"issue":"15","key":"2_CR110","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1182\/blood-2011-07-368514","volume":"118","author":"B Shao","year":"2011","unstructured":"Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L et al (2011) Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood 118(15):4015\u20134023","journal-title":"Blood"},{"issue":"4","key":"2_CR111","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","volume":"117","author":"A. Brill","year":"2010","unstructured":"Brill A, Fuchs T a, Chauhan AK, Yang JJ, Meyer SF De, Ko M, et al (2011) von Willebrand factor\u2014mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 117(4):1400\u20131407","journal-title":"Blood"},{"issue":"3","key":"2_CR112","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1538-7933.2004.00618.x","volume":"2","author":"K Vanschoonbeek","year":"2004","unstructured":"Vanschoonbeek K, Feijge MAH, Van Kampen RJW, Kenis H, Hemker HC, Giesen PLA et al (2004) Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: Subject-dependent variation in thrombogram characteristics. J Thromb Haemost 2(3):476\u2013484","journal-title":"J Thromb Haemost"},{"issue":"13","key":"2_CR113","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","volume":"96","author":"A Falanga","year":"2000","unstructured":"Falanga A, Marchetti M, Evangelista V, Vignoli A, Licini M, Balicco M et al (2000) Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 96(13):4261\u20134266","journal-title":"Blood"},{"issue":"13","key":"2_CR114","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","volume":"122","author":"T Barbui","year":"2013","unstructured":"Barbui T, Finazzi G, Falanga A (2013) Myeloproliferative neoplasms and thrombosis. Blood 122(13):2176\u20132184","journal-title":"Blood"},{"issue":"32","key":"2_CR115","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1200419109","volume":"109","author":"M. Demers","year":"2012","unstructured":"Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al (2012) Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 109(32):13076\u201313081","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"36","key":"2_CR116","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD et al (2010) Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 107(36):15880\u201315885","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2_CR117","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nm1565","volume":"13","author":"S Clark","year":"2007","unstructured":"Clark S, Ma A, Tavener S, McDonald B, Goodarzi Z, Kelly M et al (2007) Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13(4):463\u2013469","journal-title":"Nat Med"},{"issue":"8","key":"2_CR118","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1055\/s-0029-1145255","volume":"34","author":"KM Snyder","year":"2008","unstructured":"Snyder KM, Kessler CM (2008) The pivotal role of thrombin in cancer biology and tumorigenesis. Semin Thromb Hemost 34(8):734\u2013741","journal-title":"Semin Thromb Hemost"},{"key":"2_CR119","first-page":"183","volume":"7","author":"R Edwards","year":"1984","unstructured":"Edwards R, Rickles F (1984) Macrophage procoagulants. Prog Hemost Thromb 7:183\u2013209","journal-title":"Prog Hemost Thromb"},{"key":"2_CR120","first-page":"47","volume":"18","author":"N Semeraro","year":"1988","unstructured":"Semeraro N (1988) Different expression of procoagulant activity in macrophages associated with experimental and human tumors. Haemostasis 18:47\u201354","journal-title":"Haemostasis"},{"issue":"2","key":"2_CR121","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ijc.2910450208","volume":"45","author":"N Semeraro","year":"1990","unstructured":"Semeraro N, Montemurro P, Conese M, Giordano D, Stella M, Restaino A et al (1990) Procoagulant activity of mononuclear phagocytes from different anatomical sites in patients with gynecological malignancies. Int J Cancer 45(2):251\u2013254","journal-title":"Int J Cancer"},{"issue":"1","key":"2_CR122","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1182\/asheducation-2014.1.410","volume":"2014","author":"I. Pabinger","year":"2014","unstructured":"Pabinger I, Posch F (2014) Flamethrowers: blood cells and cancer thrombosis risk. Hematol Am Soc Hematol Educ Program 2014 2014(1):410\u2013417","journal-title":"Hematology"},{"issue":"3","key":"2_CR123","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1189\/jlb.3MA0916-411R","volume":"102","author":"V Granger","year":"2017","unstructured":"Granger V, Faille D, Marani V, No\u00ebl B, Gallais Y, Szely N et al (2017) Human blood monocytes are able to form extracellular traps. J Leukoc Biol 102(3):775\u2013781","journal-title":"J Leukoc Biol"},{"issue":"10","key":"2_CR124","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1007\/s13277-015-3475-2","volume":"36","author":"S Go","year":"2015","unstructured":"Go S, Kim R, Song H, Kang M, Lee U, Choi H et al (2015) Prognostic significance of the absolute monocyte counts in lung cancer patients with venous thromboembolism. Tumour Biol 36(10):7631\u20137639","journal-title":"Tumour Biol"},{"issue":"4","key":"2_CR125","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1385\/MO:22:4:353","volume":"22","author":"F Tas","year":"2005","unstructured":"Tas F, Duranyildiz D, Argon A, Og H (2005) Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer. Med Oncol 22(4):353\u2013354","journal-title":"Med Oncol"},{"key":"2_CR126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.critrevonc.2007.01.001","volume":"62","author":"JI Zwicker","year":"2007","unstructured":"Zwicker JI, Furie BC, Furie B (2007) Cancer-associated thrombosis. Crit Rev Oncol Hematol 62:126\u2013136","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"2_CR127","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood.V87.2.613.bloodjournal872613","volume":"87","author":"A Falanga","year":"1996","unstructured":"Falanga A, Marchetti M, Giovanelli S, Barbui T (1996) All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4). Blood 87(2):613\u2013618","journal-title":"Blood"},{"issue":"8","key":"2_CR128","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/01.ATV.0000134298.25489.92","volume":"24","author":"M Wouwer Van de","year":"2004","unstructured":"Van de Wouwer M, Collen D, Conway EM (2004) Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol 24(8):1374\u20131383","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2_CR129","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1055\/s-0038-1651564","volume":"69","author":"AK Lindahl","year":"1993","unstructured":"Lindahl AK, Boffa MC, Abildgaard U (1993) Increased plasma thrombomodulin in cancer patients. Thromb Haemost 69(2):112\u2013114","journal-title":"Thromb Haemost"},{"issue":"12","key":"2_CR130","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","volume":"96","author":"B Szotowski","year":"2005","unstructured":"Szotowski B, Antoniak S, Poller W, Schultheiss HP, Rauch U (2005) Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 96(12):1233\u20131239","journal-title":"Circ Res"},{"issue":"4","key":"2_CR131","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/ajh.2830400408","volume":"40","author":"WR Friedenberg","year":"1992","unstructured":"Friedenberg WR, Roberts RC, Alonso-Escolano D (1992) Relationship of thrombohemorrhagic complications to endothelial cell function in patients with chronic myeloproliferative. Am J Hematol 40(4):283\u2013289","journal-title":"Am J Hematol"},{"issue":"3","key":"2_CR132","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1532\/IJH97.E0316","volume":"79","author":"M Karakantza","year":"2004","unstructured":"Karakantza M, Giannakoulas NC, Zikos P, Sakellaropoulos G, Kouraklis A, Aktypi A et al (2004) Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera. Int J Hematol 79(3):253\u2013259","journal-title":"Int J Hematol"},{"issue":"5","key":"2_CR133","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1378\/chest.10-0157","volume":"138","author":"A Gogali","year":"2010","unstructured":"Gogali A, Charalabopoulos K, Zampira I, Konstantinidis AK, Tachmazoglou F, Daskalopoulos G et al (2010) Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers. Chest 138(5):1173\u20131179","journal-title":"Chest"},{"issue":"6","key":"2_CR134","first-page":"538","volume":"53","author":"HC Silva","year":"2006","unstructured":"Silva HC, Garcao F, Coutinho EG, De Oliveira CF, Regateiro FJ (2006) Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells. Neoplasma. 53(6):538\u2013543","journal-title":"Neoplasma."},{"issue":"1","key":"2_CR135","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1160\/TH09-09-0663","volume":"104","author":"G Cella","year":"2010","unstructured":"Cella G, Marchetti M, Vianello F, Panova-Noeva M, Vignoli A, Russo L et al (2010) Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms. Thromb Haemost 104(1):151\u2013156","journal-title":"Thromb Haemost"},{"issue":"2","key":"2_CR136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1593\/neo.05592","volume":"8","author":"PKY Goon","year":"2006","unstructured":"Goon PKY, Lip GYH, Boos CJ, Stonelake PS, Blann AD (2006) Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 8(2):79\u201388","journal-title":"Neoplasia"},{"issue":"11","key":"2_CR137","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood.V97.11.3658","volume":"97","author":"P Mancuso","year":"2001","unstructured":"Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97(11):3658\u20133662","journal-title":"Blood"},{"issue":"10","key":"2_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0047365","volume":"7","author":"T Fleitas","year":"2012","unstructured":"Fleitas T, Mart\u00ednez-Sales V, Vila V, Reganon E, Mesado D, Mart\u00edn M et al (2012) Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS ONE 7(10):1\u20136","journal-title":"PLoS ONE"},{"key":"2_CR139","doi-asserted-by":"crossref","unstructured":"Rak J, Klement G (2000) Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer. Cancer Metastasis Rev 19(1\u20132):93\u201396","DOI":"10.1023\/A:1026516920119"},{"issue":"6","key":"2_CR140","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jth.12242","volume":"11","author":"N Magnus","year":"2013","unstructured":"Magnus N, Gerges N, Jabado N, Rak J (2013) Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype. J Thromb Haemost 11(6):1197\u20131200","journal-title":"J Thromb Haemost"},{"key":"2_CR141","first-page":"4575","volume":"55","author":"J Rak","year":"1995","unstructured":"Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T et al (1995) Advances in brief mutant ras oncogenes upregulate VEGFIVPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575\u20134580","journal-title":"Cancer Res"},{"issue":"5","key":"2_CR142","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ccr.2004.09.028","volume":"6","author":"A Sparmann","year":"2004","unstructured":"Sparmann A, Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6(5):447\u2013458","journal-title":"Cancer Cell"},{"issue":"15","key":"2_CR143","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.1073\/pnas.1303302110","volume":"110","author":"VT Phan","year":"2013","unstructured":"Phan VT, Wu X, Cheng JH, Sheng RX, Chung AS, Zhuang G et al (2013) Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment. Proc Natl Acad Sci USA 110(15):6079\u20136084","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 2","key":"2_CR144","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0049-3848(09)70004-0","volume":"123","author":"FR Rickles","year":"2009","unstructured":"Rickles FR (2009) Cancer and thrombosis in women\u2014molecular mechanisms. Thromb Res 123(Suppl 2):16\u201320","journal-title":"Thromb Res"},{"issue":"12","key":"2_CR145","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1158\/1541-7786.MCR-09-0372","volume":"7","author":"S Koizume","year":"2009","unstructured":"Koizume S, Yokota N, Miyagi E, Hirahara F, Nakamura Y, Sakuma Y et al (2009) Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases. Mol Cancer Res 7(12):1928\u20131936","journal-title":"Mol Cancer Res"},{"issue":"5","key":"2_CR146","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1182\/blood-2009-10-250639","volume":"116","author":"N Magnus","year":"2010","unstructured":"Magnus N, Garnier D, Rak J (2010) Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells sure to FVIIa and PAR1- or PAR2-activat-. Blood 116(5):815\u2013819","journal-title":"Blood"},{"issue":"52","key":"2_CR147","doi-asserted-by":"publisher","first-page":"43565","DOI":"10.1074\/jbc.M112.401760","volume":"287","author":"D Garnier","year":"2012","unstructured":"Garnier D, Magnus N, Lee TH, Bentley V, Meehan B, Milsom C et al (2012) Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J Biol Chem 287(52):43565\u201343572","journal-title":"J Biol Chem"},{"issue":"3","key":"2_CR148","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-009-0041-z","volume":"97","author":"M Proven\u00e7al","year":"2010","unstructured":"Proven\u00e7al M, Berger-Thibaul N, Labb\u00e9 D, Veitch R, Boivin D, Rivard G et al (2010) Tissue factor mediates the HGF\/Met-induced anti-apoptotic pathway in DAOY medulloblastoma cells. J Neurooncol 97(3):365\u2013372","journal-title":"J Neurooncol"},{"issue":"6","key":"2_CR149","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1158\/0008-5472.CAN-08-1547","volume":"69","author":"Y Rong","year":"2009","unstructured":"Rong Y, Belozerov VE, Tucker-Burden C, Chen G, Durden DL, Olson JJ et al (2009) Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD\/activator protein-1 transcriptional activity. Cancer Res 69(6):2540\u20132549","journal-title":"Cancer Res"},{"issue":"3","key":"2_CR150","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-10-1910","volume":"71","author":"L Zhang","year":"2011","unstructured":"Zhang L, Sullivan PS, Goodman JC, Gunaratne PH, Marchetti D (2011) MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res 71(3):645\u2013654","journal-title":"Cancer Res"},{"issue":"2","key":"2_CR151","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/hmg\/ddt426","volume":"23","author":"HW Chu","year":"2014","unstructured":"Chu HW, Cheng CW, Chou WC, Hu LY, Wang HW, Hsiung CN et al (2014) A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis. Hum Mol Genet 23(2):355\u2013367","journal-title":"Hum Mol Genet"},{"issue":"14","key":"2_CR152","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-15-0390","volume":"76","author":"SK Botla","year":"2016","unstructured":"Botla SK, Savant S, Jandaghi P, Bauer AS, Mucke O, Moskalev EA et al (2016) Early epigenetic downregulation of microRNA-192 expression promotes pancreatic cancer progression. Cancer Res 76(14):4149\u20134159","journal-title":"Cancer Res"},{"issue":"43","key":"2_CR153","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.3748\/wjg.v19.i43.7758","volume":"19","author":"X-L Wu","year":"2013","unstructured":"Wu X-L (2013) MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. World J Gastroenterol 19(43):7758","journal-title":"World J Gastroenterol"},{"issue":"Suppl 1","key":"2_CR154","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0049-3848(16)30096-2","volume":"140","author":"E D\u2019Asti","year":"2016","unstructured":"D\u2019Asti E, Rak J (2016) Biological basis of personalized anticoagulation in cancer: oncogene and oncomir networks as putative regulators of coagulopathy. Thromb Res 140(Suppl 1):37\u201343","journal-title":"Thromb Res"},{"issue":"12","key":"2_CR155","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1538-7836.2004.01003.x","volume":"2","author":"S Karpatkin","year":"2004","unstructured":"Karpatkin S (2004) Does hypercoagulability awaken dormant tumor cells in the host? J Thromb Haemost 2(12):2103\u20132106","journal-title":"J Thromb Haemost"},{"issue":"13","key":"2_CR156","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1200\/JCO.2010.31.8873","volume":"29","author":"CY Vossen","year":"2011","unstructured":"Vossen CY, Hoffmeister M, Chang-Claude JC, Rosendaal FR, Brenner H (2011) Clotting factor gene polymorphisms and colorectal cancer risk. J Clin Oncol 29(13):1722\u20131727","journal-title":"J Clin Oncol"}],"container-title":["Cancer Treatment and Research","Thrombosis and Hemostasis in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-20315-3_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:44:53Z","timestamp":1610498693000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-20315-3_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030203146","9783030203153"],"references-count":156,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-20315-3_2","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"18 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}